MARSHALL WACE, LLP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 141 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,925,490
-33.1%
2,183,201
-10.7%
0.01%
-33.3%
Q2 2023$4,374,755
-43.3%
2,443,997
+23.1%
0.01%
-43.8%
Q1 2023$7,721,284
+2.7%
1,984,906
-10.2%
0.02%
-5.9%
Q4 2022$7,514,759
+765.8%
2,210,223
+1288.9%
0.02%
+750.0%
Q3 2022$868,000
+742.7%
159,137
+591.9%
0.00%
Q2 2022$103,000
+80.7%
23,000
+155.4%
0.00%
Q4 2021$57,000
-98.3%
9,006
-95.9%
0.00%
-100.0%
Q4 2020$3,366,000
+1124.0%
217,430
+1053.8%
0.02%
+800.0%
Q3 2020$275,000
-95.1%
18,845
-93.6%
0.00%
-94.9%
Q4 2019$5,645,000294,5120.04%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders